Skip to main content
. 2020 Aug 25;12:7837–7846. doi: 10.2147/CMAR.S248318

Figure 2.

Figure 2

Survival analysis of GC patients stratified by NCAPG immunoreactivity. Panel (A) Shows the disease-free survival. Panel (B) Shows the overall survival. All statistical tests were 2-sided. Significance level: P < 0.05.